Orbits Oncology’s Post

Orbits Oncology reposted this

View profile for Sangeetha Ramsagar, graphic

Transformational BioPharma Commercialization and Portfolio Strategy Executive | Experienced in Marketing Strategy and Execution | Precision Medicine | Partnerships and Alliances | Passionate People Leadeer

✨ Honored to be at Merck’s Digital Sciences Studio Showcase! ✨ Thrilled and honored to be invited as an EIR to Merck’s Digital Sciences Studio Showcase. The cohort leadership in innovative solutions and groundbreaking advancements in digital sciences was truly inspiring. Kudos to Ahmet Hamdi Cavusoglu Geof Hannigan, PhD Anita Manik, MBA, CPA, for creating an engaging and insightful program. It’s a testament to Merck's commitment to pushing the boundaries of science and technology, and it was incredible to see how digital transformation is reshaping the future of healthcare. The MDS Studio is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, with investments from the Merck Global Health Innovation Fund, Northpond Ventures and McKesson Ventures. A huge thank you to the Merck team for hosting such a visionary showcase and for inviting me to be an EIR, fostering a culture of innovation. It was great to meet like-minded innovation enthusiasts and leaders. I’m excited to see how these cutting-edge ventures will impact the Biopharma industry and beyond! Looking forward to the continued journey of innovation! 🚀 #DigitalTransformation #Innovation #Healthcare #Merck #ScienceAndTechnology Andrew Chang Abraham Lin Tyler Gilcrest Edgar Cardenas De La Hoz Binbin Chen, MD, PhD Rob Baldoni Adam Yaari Ivan Mishanin Manasa Gummalla Hannah M. Peterson, PhD Mariam Khayretdinova Mary Jane Durkin

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
David Esposito

Chief Executive Officer at ONL Therapeutics

2mo

Keep leading the way Sangeetha. Great work.

Like
Reply

To view or add a comment, sign in

Explore topics